Disease relapses in multiple sclerosis can be influenced by air pollution and climate seasonal conditions;Uticaj zagađenja vazduha i klimatskih uslova na pojavu relapsa multiple skleroze

Vojnosanitetski Pregled

Volumn 72, Issue 1, 2015, Pages 44-49

  Vojinović, Slobodan ^a,b   Savić, Dejan ^a,b   Lukić, Stevo ^a,b   Savić, Ljiljana ^c   Vojinović, Jelena ^b  

^a Clinical Center   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c Health Center Ni   (Serbia)

Author keywords

Air pollution; Climate; Multiple sclerosis; Recurrence; Sunlight; Vitamin d

Indexed keywords

VITAMIN D;

ADULT; AIR POLLUTION; ARTICLE; CLIMATE; CLOUDINESS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METEOROLOGY; MULTIPLE SCLEROSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEASONAL VARIATION; SUN SHINING; ADOLESCENT; ADVERSE EFFECTS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SEASON; SERBIA;

ADOLESCENT; ADULT; AIR POLLUTION; CLIMATE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; SERBIA;

EID: 84923221291     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP140121030V     Document Type: Article

References (41)

1. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7(3): 268-77.
2. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995; 47(4-5): 425-48.
3. Kurtzke JF. MS epidemiology worldwide. One view of current status. Acta Neurol Scand 1995; 91(Suppl 161): 23-33.
4. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand Suppl 1960; 35(147): 132-47.
5. Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254(4): 471-7.
6. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008; 194(1-2): 7-17.
7. Dwyer T, van der Mei I, Ponsonby AL, Taylor BV, Stankovich J, Mckay JD, et al. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis. Neurology 2008; 71(3): 583-9.
8. Auer DP, Schumann EM, Kümpfel T, Gössl C, Trenkwalder C. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 47(2): 276-7.
9. Ogawa G, Mochizuki H, Kanzaki M, Kaida K, Motoyoshi K, Kamakura K. Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 2004; 24(6): 417-9.
10. Abella-Corral J, Prieto JM, Dapena-Bolaño D, Iglesias-Gómez S, Noya-García M, Lema M. Seasonal variations in the outbreaks in patients with multiple sclerosis. Rev Neurol 2005; 40(7): 394-6. (Spanish)
11. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Ponsonby A. Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis. Neuroepidemiology 2008; 31(4): 271-9.
12. Sayers A, Tilling K, Boucher BJ, Noonan K, Tobias JH. Predicting ambient ultraviolet from routine meteorological data; its potential use as an instrumental variable for vitamin D status in pregnancy in a longitudinal birth cohort in the UK. Int J Epidemiol 2009; 38(6): 1681-8.
13. Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005; 11(3): 266-71.
14. Simpson S, Taylor B, Blizzard L, Ponsonby A, Pittas F, Tremlett H, van der Mei I. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68(2): 193-203.
15. Genc S, Zadeoglulari Z, Fuss HS, Genc K. The Adverse Effects of Air Pollution on the Nervous System. J Toxicol 2012; 2012: 782462.
16. Gregory A, Shendell DG, Okosun IS, Gieseker KE. Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia. Sci Total Environ 2008; 396(1): 42-51.
17. Oikonen M, Laaksonen M, Laippala P, Oksaranta O, Lilius EM, Lindgren S, et al. Ambient air quality and occurrence of multiple sclerosis relapse. Neuroepidemiology 2003; 22(1): 95-9.
18. Fonseca AC, Costa J, Cordeiro C, Geraldes R, de Sá J. Influence of climatic factors in the incidence of multiple sclerosis relapses in a Portuguese population. Eur J Neurol 2009; 16(4): 537-9.
19. Guerrero-Peral AL, Carrasco-Cavia E, Diez-Gonzalez S, Fernandez MJ, Martin-Polo JM, Bueno-Rodriguez V. Seasonal analysis of outbreaks of multiple sclerosis and their relation to different climatologic variables. Rev Neurol 2005; 41(7): 446-8. (Spanish)
20. O'Reilly MA, O'Reilly PM. Temporal Influences on Relapses of Multiple Sclerosis. Eur Neurol 1991; 31(6): 391-5.
21. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58(6): 840-6.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444-52.
23. EPA New Source Review. Regulations and Standards. Available from: http://www.epa.gov/nsr/index.html
24. Bell GS, Peacock JL, Sander JW. Seasonality as a risk factor for sudden unexpected death in epilepsy: a study in a large cohort. Epilepsia 2010; 51(5): 773-6.
25. Shoben AB, Kestenbaum B, Levin G, Hoofnagle AN, Psaty BM, Siscovick DS, et al. Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study. Am J Epidemiol 2011; 174(12): 1363-72.
26. Kasahara AK, Singh RJ, Noymer A. Vitamin D (25OHD) Serum Seasonality in the United States. PloS One 2013; 8(6): e65785.
27. Vojinović S, Vojinovic J, Cosic V, Savic V. Effects of alfacalcidol therapy on serum cytokine levels in patients with multiple sclerosis. Srp Arh Celok Lek 2005; 133(Suppl 2): 124-8. (Serbian)
28. Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1,25- dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 2007; 85(11): 2480-90.
29. Raghuwanshi A, Joshi SS, Christakos S. Vitamin D and multiple sclerosis. J Cell Bioch 2008; 105(2): 338-43.
30. Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009; 132(Pt 5): 1146-60.
31. Gillie O. A new government policy is needed for sunlight and vitamin D. Br J Dermatol 2006; 154(5): 1052-61.
32. Becklund BR, Severson KS, Vang SV, DeLuca HF. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci U S A 2010; 107(14): 6418-23.
33. Koepke P. Radiative models for the evaluation of the UV radiation at the ground. Radiat Prot Dosimetry 2009; 137(3-4): 188-92.
34. Feister U, Laschewski G, Grewe R. UV index forecasts and measurements of health-effective radiation. J Photochem Photobiol B 2011; 102(1): 55-68.
35. Turnbull DJ, Parisi AV, Schouten PW. Empirical evaluation of global vitamin D effective ultraviolet irradiances under cloudy conditions for a subtropical southern hemisphere site. Radiat Res 2010; 173(5): 703-8.
36. Bamford CR, Sibley WA, Thies C. Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 1983; 33(6): 697-701.
37. Wuthrich R, Rieder HP. The Seasonal Incidence of Multiple Sclerosis in Switzerland. Eur Neurol 1970; 3(5): 257-64.
38. Koziol JA, Feng AC. Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis. Neuroepidemiology 2004; 23(5): 217-23.
39. Tataru N, Vidal C, Decavel P, Berger E, Rumbach L. Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis. Neuroepidemiology 2006; 27(1): 28-32.
40. Embry AF, Snowdon LR, Veith R. Vitamin D and Seasonal Fluctuations of Gadolinium-Enhancing Magnetic Resonance Imaging Lesions in Multiple Sclerosis. Ann Neurol 2000; 48(2): 271-2.
41. Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, Bodolay E. The Complex Role of Vitamin D in Autoimmune Diseases. Scand J Immunol 2008; 68(3): 261-9.